General Information of the Compound
Compound ID
CP0465697
Compound Name
2-[2-(5-Bromo-indol-1-yl)-ethyl]-octahydro-pyrido[1,2-a]pyrazine
    Show/Hide
Structure
Formula
C18H24BrN3
Molecular Weight
362.315
Canonical SMILES
Brc1ccc2n(CCN3CCN4CCCCC4C3)ccc2c1
    Show/Hide
InChI
InChI=1S/C18H24BrN3/c19-16-4-5-18-15(13-16)6-8-22(18)12-10-20-9-11-21-7-2-1-3-17(21)14-20/h4-6,8,13,17H,1-3,7,9-12,14H2
    Show/Hide
InChIKey
KHCPBCHTUYSMTM-UHFFFAOYSA-N
Physicochemical Property
logP
3.5739
Rotatable Bonds
3
Heavy Atom Count
22
Polar Areas
11.41
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44460739
ChEMBL ID
CHEMBL81069
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 158 nM
   TI
   LI
   LO
   TS